(A) Tumor growth curves for CFP-B16 tumors of mice treated with ACT or PBS control. The data are represented as the mean ± SEM tumor volume (n = 12–14, three independent experiments). ns: not …
Tumor growth curves for CFP-B16 tumors of mice treated with ACT or PBS.
Density of CFSE-labeled CTLs within different organs.
(A) CFSE- and propidium iodine (PI)-based assays to assess the cytotoxicity of CTLs added to the CFP-B16 tumor cells or added to the splenocytes by flow cytometry, and the control group which was …
Representative sections of tumor-draining lymph node (TDLN), non-tumor-draining lymph node (NDLN), spleen and tumor tissues were collected from tumor-bearing mice on Days 1–3 (early stage) and Days …
CFP-B16 tumor is shown in blue (CFP), Tregs are shown in red (mRFP), and adoptively transferred CTLs are shown in green (CFSE, rarely observed). Top row: large-field images; scale bar: 500 µm. …
(A) Growth curves for the CFP-B16 tumors treated with ACT, CTX or CTX-ACT and the PBS control. The data are represented as the mean ± SEM tumor volume (n = 12–14, three independent experiments). ns: …
Growth curves for the CFP-B16 tumors treated with ACT, CTX, CTX-ACT or PBS control.
(A,B) Growth curves for the CFP-B16 tumors in (A) C57BL/6 and (B) BALB/c nude mice treated with different doses of CTX (50, 100 or 150 mg kg−1), different doses of CTX (50, 100 or 150 mg kg−1) …
Growth curves for the CFP-B16 tumors in C57BL/6 and BALB/c nude mice treated with different doses of CTX, different doses of CTX combined with ACT treatment and PBS control.
(A) Density of Tregs and (B) adoptive CTLs were determined by counting the number of mRFP-Tregs and CFSE-labeled CTLs per mm2 in the tumor area. The data are represented as the mean ± SEM (n = 10–12 …
Density of Tregs and adoptive CTLs in the tumor area.
(A–D) Time-lapse images of CTLs with time-coded motion trajectories (color scale represents the duration). (A,C) Images of CTLs (green) at the periphery (near the blue area, A) or in the parenchyma …
Mean displacement (μm) versus the square root of the time (min1/2) of the CTLs at the tumor periphery on Day 1.
Data listed in the excel files are displacements. Displacement is a function of time. Each column in the excel files lists displacements corresponding to one time. The time values are 0.5 min, 1 min, 1.5 min, and so on, in turn.
Mean displacement (μm) versus the square root of the time (min1/2) of the CTLs at the tumor periphery on Day 3.
Mean displacement (μm) versus the square root of the time (min1/2) of the CTLs at the tumor periphery on Day 5.
Mean displacement (μm) versus the square root of the time (min1/2) of the CTLs at the tumor periphery on Day 6.
Mean displacement (μm) versus the square root of the time (min1/2) of the CTLs in the tumor parenchyma on Day 3.
Mean displacement (μm) versus the square root of the time (min1/2) of the CTLs in the tumor parenchyma on Day 5.
Mean displacement (μm) versus the square root of the time (min1/2) of the CTLs in the tumor parenchyma on Day 6.
Linear fitting results of MD (mean displacement) of adoptive CTLs at the tumor periphery on Day 1, Day 3, Day 5 and Day 6.
Linear fitting results of MD (mean displacement) of adoptive CTLs in the tumor parenchyma on Day 3, Day 5 and Day 6.
Scatter plots of the mean velocity, confinement ratio, and arrest coefficient of the adoptive CTLs at the tumor periphery or in the tumor parenchyma on different days.
(A) In vivo time-lapse images of the endogenous GFP T cells (green) and adoptive CTLs (red) in the CFP-B16 tumor area (blue). Mice were treated with ACT or CTX-ACT. Scale bar: 100 μm. (B) …
Quantification of endogenous GFP T cells in the differently treated groups on Day 5.
Scatter plots of the mean velocity, confinement ratio, and arrest coefficient of the GFP T cells in tumor areas in the differently treated groups on Day 5.
(A) Ex vivo analysis and characterization of the GFP cells in the tumors of Cxcr6+/gfp mice that were treated differently. (B) Percentage of GFP cells in the tumors of mice following the different …
(A) Experimental procedure for long-term intravital imaging of TIIs in the tumor microenvironment. (B) In vivo time-lapse images of EGFP TIIs (green) in the CFP-B16 tumor area (blue) from Day 0 to …
Scatter plots of the mean velocity, confinement ratio, and arrest coefficient of EGFP TIIs in tumor areas on different days.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs on Day 0.
Data listed in the excel files are displacements. Displacement is a function of time. Each column in the excel files lists displacements corresponding to one time. The time values are 0.5 min, 1 min, 1.5 min, and so on, in turn.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs on Day 1.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs on Day 2.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs on Day 3.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs on Day 4.
Linear fitting results of MD (Mean displacement) of TIIs at tumor areas on Day 0–Day 4.
(A) In vivo time-lapse images of the EGFP TIIs in the CFP-B16 tumor area on Day 1. Mice were treated with ACT, CTX, CTX-ACT or PBS control. Green arrows represent TIIs displacement, and blue areas …
Scatter plots of the mean velocity, confinement ratio, and arrest coefficient of the EGFP TIIs in the different treatment groups.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs in the PBS group.
Data listed in the excel files are displacements. Displacement is a function of time. Each column in the excel files lists displacements corresponding to one time. The time values are 0.5 min, 1 min, 1.5 min, and so on, in turn.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs in the ACT group.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs in the CTX group.
Mean displacement (μm) versus the square root of the time (min1/2) of the TIIs in the CTX-ACT group.
Linear fitting results of MD (Mean displacement) of TIIs at tumor areas in the different treatment groups on Day 1.
(A) Representative tumor sections stained with CD3, Ly6G and F4/80. Most of the EGFP TIIs at the tumor periphery were Ly6G+ and F4/80+. Scale bar: 50 μm. (B) Histopathology of HE-stained tumor …
Percentage of neutrophils among TIIs at the periphery of the tumors in mice that received different treatments.
(A) Large-field intravital imaging of DCs (green) and Tregs (red) in the CFP-B16 tumor area (blue) on Day 3. Top row: large-field images; scale bar 500 µm. Bottom row: images of the region of …
Density of DCs in the tumor areas in the different treatment groups.
(A) Metronomic therapy schedule of the CTX-ACT treatment. (B) Growth curves for CFP-B16 tumors in the different treatment groups. The data are represented as the mean ± SEM tumor volume (n = 12–15, …
Growth curves for CFP-B16 tumors in the different treatment groups
Step 1: CFP-B16 tumor cells grew and Tregs accumulated in the tumor area before CTX treatment. Step 2: CTX treatment depleted most Tregs, blocking the formation of an ‘immunosuppressive ring’. Step …
Supernatants are normalized to the cell numbers.
Top row: percentage changes of CD4+ cells, CD8+ T cells, and CD4+CD25+ Tregs in the blood of normal mice, PBS-treated tumor-bearing mice, and CTX metronomically treated tumor-bearing mice on days 5, …
The markers of neutrophils are CD11b+Ly6G+Ly6Clow, and markers of MDSCs are CD11b+Gr1+.
Most of the EGFP TIIs at the tumor periphery were Ly6G+ and F4/80+. Scale bar: 50 μm.
The 3D time-lapse images were acquired as a 30 μm z-stack. Adoptively transferred CTLs are shown in green (CFSE-labeled), and the B16 tumor cells are shown in blue (CFP). Scale bar: 70 μm.
The 3D time-lapse images were acquired as a 30 μm z-stack. Adoptively transferred CTLs are shown in green (CFSE-labeled), and the B16 tumor cells are shown in blue (CFP). Scale bar: 70 μm.
The 3D time-lapse images were acquired as a 30 μm z-stack. Adoptively transferred CTLs are shown in green (CFSE-labeled), and the B16 tumor cells are shown in blue (CFP). Scale bar: 70 μm.
The 3D time-lapse images were acquired as a 30 μm z-stack. Adoptively transferred CTLs are shown in green (CFSE-labeled), and the B16 tumor cells are shown in blue (CFP). Scale bar: 70 μm.
Time-lapse images were collected for 15 min. Endogenous T cells are shown in green (GFP labeled), adoptive CTLs are shown in red (CMTPX labeled) and the B16 tumor cells are shown in blue (CFP labeled…
Time-lapse images were collected for 10 or 15 min. Endogenous TIIs are shown in green (EGFP), and the B16 tumor cells are shown in blue (CFP). Scale bar: 70 μm.
Time-lapse images were collected for a duration of 10 or 15 min. Mice were mock-treated (with PBS) or treated with CTX, ACT, or CTX-ACT as indicated. Endogenous TIIs are shown in green …
The CellTracking_GUI.m is the main program of the Post-TrackObject software.
The Post-TrackObject software is designed based on the Matlab (R2012, MathWorks) GUI.
The CellTracking_GUI.fig is the main user interface of the Post-TrackObject software
The CellTracking_GUI_Trajectory.m is the subprogram of the Post-TrackObject software
The conrat.m is the subprogram of the Post-TrackObject software
The dmean_motcoe.m is the subprogram of the Post-TrackObject software
The mdmot_eb.m is the subprogram of the Post-TrackObject software
The mean_sem.m is the subprogram of the Post-TrackObject software
The trajectory.m is the subprogram of the Post-TrackObject software
The vmean_arrcoe.m is the subprogram of the Post-TrackObject software
The CellTracking_GUI_Trajectory.fig is the subinterface which corresponds to the subprogram CellTracking_GUI_Trajectory.m.